Defective production of both leukemia inhibitory factor and type 2 T- helper cytokines by decidual T cells in unexplained recurrent abortions

Nature Medicine

Volumn 4, Issue 9, 1998, Pages 1020-1024

  Piccinni, Marie Pierre ^a   Beloni, Lucio ^a   Livi, Claudia ^a   Maggi, Enrico ^a   Scarselli, Gianfranco ^a   Romagnani, Sergio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4; LEUKEMIA INHIBITORY FACTOR; PROGESTERONE;

ARTICLE; BLASTOCYST; CLINICAL ARTICLE; CONTROLLED STUDY; DECIDUA; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETOMATERNAL TRANSFUSION; HELPER CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; NIDATION; PREGNANCY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RECEPTOR UPREGULATION; RECURRENT ABORTION; T LYMPHOCYTE;

ABORTION, HABITUAL; ADULT; CELLS, CULTURED; CYTOKINES; DECIDUA; FEMALE; GROWTH INHIBITORS; HUMANS; INTERLEUKIN-4; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; LYMPHOKINES; MALE; PREGNANCY; PROGESTERONE; T-LYMPHOCYTES; TH2 CELLS; UP-REGULATION;

EID: 0031695515     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/2006     Document Type: Article

References (33)

1. Stewart, C.L. et al. Blastocyst implantation depends on maternal expression of leukemia inhibitory factor. Nature. 359, 76-79 (1992).
2. Delage, G. et al. In vitro endometrial secretion of human interleukin for DA cells/leukaemia inhibitory factor by explant cultures from fertile and unfertile women. Human Reprod. 10, 2483-2488 (1995)
3. Laird, S.M. et al. The production of leukemia inhibitory factor by human endometrium: presence in uterine flushings and production by cells in culture. Human Reprod. 12, 569-574 (1997)
4. Wegmann, T.G., Lin, H., Guilbert, L. & Mossman, T.R. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol. Today. 14, 353-356 (1990).
5. Chaouat, G. et al. Control of survival in CBA X DBA/2 mice by lymphokine therapy. J. Reprod. Fertil. 89, 447-458 (1990).
6. Chaouat, G. et al. IL-10 prevents naturally occuring fetal loss in the CBA X DBA/2 mating combination and local defect in IL-10 production in this abortion prone combination is corrected by in vivo injection of IFN-τ. J. Immunol. 154, 4261-4268 (1995).
7. Suthanthiran, M. & Strom, T.B. Immunobiology and immunopharmacology of organ allograft rejection. J. Clin. Immunol. 15, 161-171 (1995).
8. Nickerson, P. et al. Cytokines and the Th1/Th2 paradigm in transplantation. Curr. Opin. Immunol. 6, 757-764 (1994).
9. Da Silva, J.A. & Spentor, T.D. The role of pregnancy in the course and aetiology of rhumatoid arthritis. Clin. Research. 11, 189-194 (1992).
10. Piccinni, M.-P. et al. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J. Immunol. 155, 128-133 (1995).
11. Szekenes-Bartho, J. & Wegmann, T.G. A progesterone-dependent immunomodulatory protein alters the Th1/Th2 balance. J. Reprod. Immunol. 31, 81-95 (1996).
12. Deneys, V. & De Bruyere, M. Immunological tolerance of fetal allograft: efficacy of immunotherapy and IL-4 and TNF alpha serum levels in recurrent abortion. Transplant. Proc. 29: 2467-2469 (1997).
13. Manetti, R. et al. Natural killer stimolatory factor (NKSF/IL-12) induces Th1-type specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177, 1199-1204 (1993).
14. Maggi, E. et al. Reciprocal regulatory effects of IFN-g and IL-4 on the in vitro development of human Th1 and Th2 clones. J. Immunol. 148, 2142-2147 (1992).
15. Bhatt, H., Brunet, L.J. & Stewart, C.L. Uterine expression of leukemia inhibitory factor coincides with the onset of blastocyst implantation. Proc. Natl. Acad. Sci. USA. 88, 11408-11412 (1991).
16. Charnock-Jones, D.S., Sharkey, A.M., Fenwick, P. & Smith, S.K. Leukemia Inhibitory factor mRNA concentration peaks in human endometrium at the time of implantation and the blastocyst contains mRNA for the receptor at this time, J. Reprod. Fertil. 101, 421-426 (1994).
17. King, A., Jokhi, P.P., Smith, S.K., Sharkey A.M. & Loke, Y.W. Screening for cytokine mRNA in human villous and extravillous trophoblasts using the reversetranscriptase polymerase chain reaction (RT-PCR). Cytokine 7, 364-371 (1995).
18. Vogiagis, D., March, M.M., Fry, R.C. & Salamonsen, L.A. Leukemia inhibitory factor in human endometrium thoughout the menstrual cycle. J. Endocrinol. 148, 95-102 (1996).
19. Kojima, K. et al. Expression of leukemia Inhibitory factor (LIF) receptor in human placenta: a possible role of LIF in the growth and differentiation of trophoblasts. Hum. Reprod. 10, 1907-1911 (1995).
20. Jokhi, P.P., King, A., Sharkey, A.M., Smith, S.K. & Loke, Y.W. Screening of cytokine messenger ribonucleic acids in purified human decidual lymphocyte populations by the reverse transcriptase polymerase chain reaction. J. Immunol. 153, 4427-4435 (1994).
21. Hill, J.A., Haimovici, F. & Anderson, D.J. The effects of soluble products of activated lymphocytes and macrophages on blastocyst implantation events in vitro. Biol. Reprod. 44, 69-75 (1991).
22. Berkovitz, R.S., Hill, J.A., Kurtz, C.B. & Anderson, D.J. Effects of products of activated leukocytes (lymphokines and monokines) on the growth of malignant trophoblast cells in vitro. Am. J. Obstet. Gynecol. 158, 199-203 (1988).
23. Lin, H., Mosmann, T.R., Guilbert, L., Tuntipopipat, S. & Wegmann, T.G. Synthesis of T helper 2-type cytokines at maternal-fetal interface. J. Immunol. 151, 4562-4573 (1993).
24. Krishnan, L., et al. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-γ responses and increased production of helper 2 cytokines. J. Immunol. 15, 644-652 (1996).
25. Krishnan, L., Guilbert, L.J., Wegmann, T.G., Belosevic, M. & Mosmann, T.R. T helper response against Leishmania major in pregnant C57BL/6 mice increases implantation failure and fetal resorptions. Correlation with increased IFN-γ and TNF and reduced IL-10 production by placental cells. J. Immunol. 156, 653-662 (1996).
26. Hill, J.A., Polgar, K. & Anderson, D.J. T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion. J. Am. Med. Assoc. 273, 1933-1936 (1995).
27. White A, Wang, M.W., King, I.S. & Heap, R.B. Biotinylated anti-progesterone monoclonal antibodies specifically target the uterine epithelium and block implantation in the mouse. J. Reprod. Immunol. 21, 127-138 (1992).
28. Chaouat, G., Menu, R., Kinski, R., David, F. & Wegmann, T.G. Immunoregulatory role of the placenta. J. Immunol. Immunopharmacol. 10, 45-50 (1990).
29. Croy, B.A. et al. Characterization of cytokine production by metrial gland and granulated metrial gland cells. J. Reprod. Immunol. 19, 149-166 (1991).
30. Lavranos, T.C., Rathjen, P.D. & Seamark, R.F. Trophic effects of myeloid leukemia inhibitory factor (LIF) on mouse embryo. J. Reprod. Fertil. 105, 331-338 (1995).
31. Arici, A., Engin, O., Attar, E. & Olive, DL. Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in human endometrium. J. Clin. Endocrinol. Metab. 80, 1908-1915 (1995).
32. Piccinni, M.-P. & Romagnani, S. Regulation of fetal allograft survival by hormone-controlled Th1-and Th2-type cytokines. Immunol. Res. 15, 141-150 (1996).
33. Piccinni, M.-P. et al. Abnormal production of T helper 2 cytokines interleukin-4 and interleukin-5 by T cells from newborns with atopic parents. Eur. J. Immunol. 26, 2296-2298 (1996).